The estimated Net Worth of Kevin P Corcoran is at least $266 Mille dollars as of 24 November 2017. Kevin Corcoran owns over 256 units of Pacific Biosciences of California Inc stock worth over $265,732 and over the last 12 years Kevin sold PACB stock worth over $0.
Kevin has made over 4 trades of the Pacific Biosciences of California Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Kevin exercised 256 units of PACB stock worth $502 on 24 November 2017.
The largest trade Kevin's ever made was exercising 84,183 units of Pacific Biosciences of California Inc stock on 14 June 2017 worth over $164,999. On average, Kevin trades about 12,813 units every 111 days since 2013. As of 24 November 2017 Kevin still owns at least 158,174 units of Pacific Biosciences of California Inc stock.
You can see the complete history of Kevin Corcoran stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1380 WILLOW ROAD, MENLO PARK, CA, 94025.
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan e Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include: